<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04273087</url>
  </required_header>
  <id_info>
    <org_study_id>STP1-C003</org_study_id>
    <nct_id>NCT04273087</nct_id>
  </id_info>
  <brief_title>Characterization of a Clinical Subpopulation With Autism Spectrum Disorder</brief_title>
  <official_title>Characterization of a Clinical Subpopulation With Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stalicla SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stalicla SA</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective for this research study is to gather additional information to help
      confirm identification of new subgroups within the autism spectrum.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of non-behavioral phenotypical traits in sub-populations with Autism Spectrum Disorder (ASD)</measure>
    <time_frame>Day 0</time_frame>
    <description>A questionnaire will be administered to collect non-behavioral traits and co-occurring conditions data of the participants</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Clinical signs and symptoms</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cincinnati Children's Hospital Primary Care Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants previously diagnosed with ASD (DSM-5) supported by either autism
             diagnostic interview revised (ADI-R) or Autism Diagnostic Observation Scale (ADOS-2)
             scores

          -  Available health records within the first 2 years of life

          -  Participants must have a parent or reliable caregiver who agrees to provide
             information about the participant

        Non-Inclusion Criteria:

          -  Genetically identified ASD (syndromic form of autism, e.g. fragile X)

          -  Episode of fever (i.e. ≥100.5 °F) or clinically significant illness without fever (as
             judged by the Investigator), within 10 days before the study visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig A Erickson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CCHMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivia Walter</last_name>
    <phone>513.636.9373</phone>
    <email>Olivia.Walter@cchmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig A Erickson, MD</last_name>
      <phone>513-803-8653</phone>
      <email>autism@cchmc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 6, 2020</study_first_submitted>
  <study_first_submitted_qc>February 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

